Literature DB >> 3986652

Perioperative complications in patients with anthracycline chemotherapeutic agents.

F A Burrows, P R Hickey, S Colan.   

Abstract

The anaesthetic records of 68 patients ranging in age from 0.5 to 22 years were reviewed to determine the incidence of perioperative cardiovascular complications in patients with a history of anthracycline drug therapy. One hundred and eleven anaesthetics were retrospectively reviewed and seven cardiovascular complications (hypotension) were identified for an incidence of 6.3 per cent. Of these, only two could be definitely attributed to perioperative myocardial dysfunction. Both of these patients had a history of congestive heart failure. Three of four patients with a history of congestive heart failure developed complications. In evaluating possible preoperative predictions of perioperative cardiovascular complications, only a history of congestive heart failure bore a statistical significant relationship. There was no relationship between anaesthetic technique and perioperative cardiovascular complications. Two additional cardiovascular complications occurred more than 48 hours postoperatively and their significance is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986652     DOI: 10.1007/bf03010041

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  16 in total

1.  A clinicopathologic analysis of adriamycin cardiotoxicity.

Authors:  E A Lefrak; J Pitha; S Rosenheim; J A Gottlieb
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

2.  Late cardiac effects of therapeutic mediastinal irradiation. Assessment by echocardiography and radionuclide angiography.

Authors:  J S Gottdiener; M J Katin; J S Borer; S L Bacharach; M V Green
Journal:  N Engl J Med       Date:  1983-03-10       Impact factor: 91.245

Review 3.  The anthracycline antineoplastic drugs.

Authors:  R C Young; R F Ozols; C E Myers
Journal:  N Engl J Med       Date:  1981-07-16       Impact factor: 91.245

4.  Echocardiographic assessment of anthracycline cardiotoxicity in children.

Authors:  A B Lewis; R Pilkington; M Takahashi; S E Siegel
Journal:  Med Pediatr Oncol       Date:  1978

5.  The cardiotoxicity of adriamycin and daunomycin in children.

Authors:  A C Gilladoga; C Manuel; C T Tan; N Wollner; S S Sternberg; M L Murphy
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

6.  Echographic determination of left ventricular volumes in pediatric patients.

Authors:  R A Meyer; J Stockert; S Kaplan
Journal:  Circulation       Date:  1975-02       Impact factor: 29.690

7.  Risk factors for doxorubicin-induced congestive heart failure.

Authors:  D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

8.  Clinical spectrum of anthracycline antibiotic cardiotoxicity.

Authors:  M R Bristow; M E Billingham; J W Mason; J R Daniels
Journal:  Cancer Treat Rep       Date:  1978-06

9.  Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children.

Authors:  A B Lewis; V L Crouse; W Evans; M Takahashi; S E Siegel
Journal:  Pediatrics       Date:  1981-07       Impact factor: 7.124

10.  Early anthracycline cardiotoxicity.

Authors:  M R Bristow; P D Thompson; R P Martin; J W Mason; M E Billingham; D C Harrison
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

View more
  3 in total

Review 1.  Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.

Authors:  Lei Xi; Shu-Guang Zhu; Anindita Das; Qun Chen; David Durrant; Daniel C Hobbs; Edward J Lesnefsky; Rakesh C Kukreja
Journal:  Nitric Oxide       Date:  2012-04-05       Impact factor: 4.427

2.  Cardiovascular autonomic function in anthracycline-treated breast cancer patients.

Authors:  M Viniegra; M Marchetti; M Losso; A Navigante; S Litovska; A Senderowicz; L Borghi; J Lebron; D Pujato; H Marrero
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Anticancer Chemotherapy and it's Anaesthetic Implications (Current Concepts).

Authors:  R P Gehdoo
Journal:  Indian J Anaesth       Date:  2009-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.